General Information of Drug Transporter (DT)
DT ID DTD0232 Transporter Info
Gene Name SLC26A4
Transporter Name Sodium-independent chloride/iodide transporter
Gene ID
5172
UniProt ID
O43511
Post-Translational Modification of This DT
Overview of SLC26A4 Modification Sites with Functional and Structural Information
Sequence
PTM type
X-Phosphorylation X: Amino Acid

Phosphorylation

  Serine

          3 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC26A4 [1]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

17

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC26A4 Serine 17 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC26A4 [2]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

355

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC26A4 Serine 355 has the potential to affect its expression or activity.

  PTM Phenomenon 3

Have the potential to influence SLC26A4 [3]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

642

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC26A4 Serine 642 has the potential to affect its expression or activity.

  Threonine

          2 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC26A4 [3]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

631

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC26A4 Threonine 631 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC26A4 [4]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

717

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC26A4 Threonine 717 has the potential to affect its expression or activity.

  Tyrosine

          2 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC26A4 [1]

Role of PTM

Potential impacts

Modified Residue

Tyrosine

Modified Location

16

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC26A4 Tyrosine 16 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC26A4 [1]

Role of PTM

Potential impacts

Modified Residue

Tyrosine

Modified Location

20

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC26A4 Tyrosine 20 has the potential to affect its expression or activity.
References
1 iTRAQ labeling is superior to mTRAQ for quantitative global proteomics and phosphoproteomics. Mol Cell Proteomics. 2012 Jun;11(6):M111.014423.
2 Robust, Reproducible, and Economical Phosphopeptide Enrichment Using Calcium Titanate. J Proteome Res. 2019 Mar 1;18(3):1411-1417.
3 An Augmented Multiple-Protease-Based Human Phosphopeptide Atlas. Cell Rep. 2015 Jun 23;11(11):1834-43.
4 TSH regulates pendrin membrane abundance and enhances iodide efflux in thyroid cells. Endocrinology. 2012 Jan;153(1):512-21.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.